• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Physiological function of thymidine phosphorylase and the involvement of the enzyme in tumor growth

Research Project

Project/Area Number 10470043
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionKagoshima University

Principal Investigator

AKIYAMA Shinichi  Kagoshima University, Faculty of Medicine, Professor, 医学部・腫瘍研究施設, 教授 (60117413)

Co-Investigator(Kenkyū-buntansha) TANI Ayako  Kagoshima University, Faculty of Medicine, Research Associate, 医学部・腫瘍研究施設, 助手 (70284867)
SUMIZAWA Tomiyuki  Kagoshima University, Faculty of Medicine, Research Associate, 医学部・腫瘍研究施設, 助手 (90206582)
FURUKAWA Tatsushiko  Kagoshima University, Faculty of Medicine, Research Associate, 医学部・腫瘍研究施設, 助手 (40219100)
小松 正治  鹿児島大学, 医学部・腫瘍研究施設, 講師 研究機関研究員
KOMATSU M  Kagoshima University, Faculty of Medicine, Instructor
Project Period (FY) 1998 – 1999
KeywordsThymidine phosphorylase / 2-deoxy-D-ribose / 2-deoxy-L-ribose / TPI / hypoxia / apotosis / metastasis / angiogenesis
Research Abstract

Thymidine phosphorylase (TP) is an enzyme involved in the reversible conversion of thymidine to thymine and is identical to an angiogenic factor, platelet-derived endothelial cell growth factor (PD-ECGF), TP is expressed at higher levels in a wide variety of solid tumors than in the adjacent nonneoplastic tissues. KB/TP cells transfected with a PD-ECGF/TP cDNA were resistant to hypoxia-induced apoptosis. Among the degradation products of thymidine produced by PD-ECGF/TP, 2-deoxy-D-ribose partially prevented hypoxia-induced apoptosis, 2-Deoxy-L-ribose abrogated the effects of 2-deoxy-D-ribose. These findings suggested that TP can confer resistance to apoptosis induced by hypoxia and the degeadation products of thymidine are involved in this resistance.
In hypoxic condition, the level of HIF-1 α is elevated and the expression levels of Bcl-2 and Bcl-XL are lowered. 2-Deoxy-D-ribose inhibited the response of the cells to hypoxia. Patients with TP-positive colon and esophageal tumors have a … More poorer prognosis than those with TP-negative tumors. We have recently synthesized a new TP inhibitor (TPI), 5-chloro-6-[1-(2-iminopyrrolidinyl)methyl] uracil hydrochloride. We investigated the effect of TPI on angiogenesis in KB cells transfected with PD-ECGF cDNA, KB/TP, and a mock transfecta, KB/CV, using the mouse dorsal air sac assay model. We found that KB/TP cells had a higher angiogeneic ability than KB/CV cells and that TPI completely suppressed angiogenesis by KB/TP. Furthermore, at a dose of 50 mg/kg/day, TPI considerably decreased the growth rate of KB/TP cells xenografted into nude mice. Microvessel density in KB/TP tumors was higher than that in KB/CV tumors, and TPI did not significantly change the density in either of the tumors. The apoptotic index in KB/TP tumors was significantly lower than that in KB/CV tumors, and TPI significantly increased the apoptotic index in KB/TP tumors but not in KB/CV tumors. TPI inhibited the high chemotactic motility and basement membrane invasion of KB/TP cells. In nude mice, oral administration of TPI suppressed macroscopic liver metastases of highly metastasizing KB/TP cells. These findings demonstrate that TP plays a key role in invasiveness and metastasis of TP-expressing solid tumors, and TPI might be a novel anti-metastatic agent for blood-borne metastasis. Less

  • Research Products

    (33 results)

All Other

All Publications (33 results)

  • [Publications] Takebayashi, Y.: "Thymidine phosphorylase in human esophageal squmous cell carcinoma"Cancer. 85. 282-289 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Chu, X.-Y.: "Active efflux of CPT-11 and its metabolites in human KB-derived cell lines"J. Pharmacol. Exp. Ther.. 288. 753-741 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fukuiwa, T.: "Expression of thynidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics"Cancer. 85. 960-969 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fukuda, S.: "expression of vascular endothelial growth factor (VEGF) in testicular germ cell tumors as an indicator of metastatic disease"Cancer. 85. 1323-1330 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Chen, Z.-S.: "An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cells"Cancer Lett.. 138. 13-22 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ueda, K.: "Differences in substrate specificity among GS-X pump family members: Comparison between MRP and a novel transporter expressed on a cisplatin-resistant cell line (KOP-4)"Jpn. J. Cancer Res.. 90. 439-447 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Matsushita, S.: "The effcts of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors"cancer Res.. 59. 1911-1961 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Chen, Z. S.: "ATP-dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P"Mol. Pharmacol.. 55. 921-928 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitazono, M.: "Multidrug resistance reversing agents on the transporting activity of human canalicular multispecific organic anion transporter (cMOAT)"Mol. Pharmacol.. 56. 1219-1228 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Aoki, S.: "Reversal of multidrug resistance in human carcinoma cell line by agosteroids, marine spongean sterols"Tetrahedron. 55. 13965-13972 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawabe, T.: "Enhanced transport of anticancer agents and leukotriene C4 by thehuman canalicular multispecific organic anion transporter"FEBS Lett.. 465. 327-331 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hasui, K.: "Immunohistochemical analysis of thymidine phosphorylase overexpression in malignant lymphomas (ML), especially in adult T-cell leukemia/lymphoma (ATLL)"Dendritic Cells. 9. 15-25 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] arima. J.: "Expression of thymidine phosphorylase as an indicator of poor prognosis in human transitional cell caecinoma"Cancer. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimaoka, S.: "Role of thymidine phosphorylase expression in the invasion of gastric carcinomas"Cancer. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Komatsu, M.: "Copper transporting P-type ATPase (ATP7B) is associated with cisplatin resistance"Cancer Res.. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takebayashi, Y., et al.: "Thymidine phosphorylase in human esophageal squamous cell carcinoma."Cancer. 85. 282-289 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Chu, X.Y., et al Akiyama, S., and Sugiyama Y.: "Active efflux of CPT-11 and its metabolites in human KB-derived cell lines."J. Pharmacol. Exp. Ther.. 288. 753-741 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fukuiwa, T.,et al.: "Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics."Cancer. 85. 960-969 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fukuda, S., et al.: "Expression of vascular endothelial growth factor (VEGF) in testicular germ cell tumors as an indicator of metastatic disease."Cancer. 85. 1323-1330 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Chen, Z.-S., et al.: "An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cells."Cancer Lett.. 138. 13-22 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ueda, K., et al.: "Differences in substrate specificity among GS-X pump family members: Comparison between MRP and a novel transporter expressed on a cisplatin-resistant cell line (KCP-4)"Jpn. J. Cancer Res.. 90. 439-447 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Matsushita, S., et al.: "The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors."Cancer Res.. 59. 1911-1961 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Chen, Z.-S., et al.: "ATP-dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104."Mol. Pharmacol. 55. 921-928 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitazono, M., et al.: "Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells."J. Natl. Cancer Inst.. 91. 1647-1653 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Chen, Z.-S., et al.: "Effect of multidrug resistance reversing agents on the transporting activity of human canalicular multispecific organic anion transporter(cMOAT)"Mol. Pharmacol. 56. 1219-1228 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Aoki,S., et al.: "Reversal of multidrug resistance in human carcinoma cell line by agosterols, marine spongean sterols"Tetrahedron. 55. 13965-13972 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kawabe, T., et al.: "Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter"FEBS Lett.. 465. 327-331 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hasui, K., et al.: "Immunohistochemical analysis of thymidine phosphorylase overexpression in malignant lymphomas (ML), especially in adult T-cell leukemia/lymphoma (ATLL)."Dendritic Cells. 9. 15-25 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ogawa, K., et al.: "Clinicopathological and prognostic significance of thymidine phosphorylase expression in gastric carcinoma."Aniticancer Res.. 19. 4363-4367 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Arima, J., et al.: "Expression of thymidine phosphorylase as an indicator of poor prognosis in human transitional cell carcinoma."Cancer. 88. 1131-1138 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Komatsu, M., et al.: "Copper transporting P-type ATPase (ATP7B) is associated with cisplatin resistance."Cancer Res.. 60. 312-1316 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ren X-Q. ,et al: "Functional comparison between YCF1 and MRP1 expressed in Sf21 insect cells."Biochem. Biophys. Res. Commun.. 270. 608-615 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimaoka, S., et al.: "Role of thymidine phosphorylase expression in the invasion of gastric carcinomas."Cancer. 88. 2220-2227 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi